New school program targets vaping and pill misuse in 7- to 11-year-olds

NCT ID NCT07162155

Not yet recruiting Prevention Sponsor: Christopher Williams Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This trial tests a school-based program that combines classroom lessons with online modules to reduce the risk of vaping and prescription drug misuse in upper elementary students (ages 7-11). About 3,000 students from 30 schools will either receive the program or continue with standard health education. Researchers will compare changes in behaviors, attitudes, and knowledge about vaping and prescription drugs over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: School-based hybrid intervention (classroom sessions and e-learning modules)
What this could lead to: If it works, this program could provide an effective way to prevent vaping and prescription drug misuse in upper elementary students.
What could go wrong: This is an early-stage trial measuring attitudes and behaviors, not actual drug use. Results may not generalize to all schools or lead to long-term prevention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for E-CIG USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Prescription Drug Misuse substance abuse Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

E-CIG USE PRESCRIPTION DRUG MISUSE VAPING

Contacts and locations

Locations

National Health Promotion Associates

White Plains, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.